Amalgamated Bank’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-11,966
Closed -$2.94M 2979
2022
Q3
$2.94M Buy
11,966
+126
+1% +$34K 0.03% 657
2022
Q2
$2.93M Sell
11,840
-76
-0.6% -$20.5K 0.03% 701
2022
Q1
$3.95M Buy
11,916
+522
+5% +$161K 0.03% 606
2021
Q4
$4.09M Buy
11,394
+1,335
+13% +$451K 0.03% 622
2021
Q3
$3.27M Sell
10,059
-418
-4% -$142K 0.03% 716
2021
Q2
$3.27M Buy
10,477
+7,744
+283% +$2.38M 0.03% 748
2021
Q1
$871K Sell
2,733
-136
-5% -$43.5K 0.03% 655
2020
Q4
$930K Sell
2,869
-5
-0.2% -$1.38K 0.04% 585
2020
Q3
$796K Sell
2,874
-83
-3% -$23.9K 0.03% 574
2020
Q2
$714K Sell
2,957
-4,591
-61% -$922K 0.03% 607
2020
Q1
$1.1M Sell
7,548
-253
-3% -$42K 0.03% 584
2019
Q4
$1.33M Buy
7,801
+491
+7% +$91K 0.02% 686
2019
Q3
$1.3M Buy
7,310
+1,428
+24% +$309K 0.03% 641
2019
Q2
$1.53M Sell
5,882
-567
-9% -$150K 0.04% 562
2019
Q1
$1.84M Buy
6,449
+134
+2% +$44.5K 0.04% 427
2018
Q4
$2.05M Sell
6,315
-133
-2% -$46.2K 0.06% 307
2018
Q3
$2.9M Sell
6,448
-129
-2% -$50.9K 0.07% 252
2018
Q2
$2.69M Sell
6,577
-2,612
-28% -$946K 0.07% 260
2018
Q1
$2.67M Buy
9,189
+558
+6% +$141K 0.07% 265
2017
Q4
$1.62M Buy
8,631
+443
+5% +$82.7K 0.04% 467
2017
Q3
$1.38M Sell
8,188
-29
-0.4% -$4.38K 0.04% 469
2017
Q2
$1.18M Buy
8,217
+1,823
+29% +$245K 0.04% 550
2017
Q1
$801K Sell
6,394
-1,286
-17% -$149K 0.04% 563
2016
Q4
$865K Buy
7,680
+749
+11% +$86.8K 0.04% 552
2016
Q3
$891K Buy
6,931
+6
+0.1% +$719 0.05% 432
2016
Q2
$859K Buy
6,925
+2,352
+51% +$234K 0.05% 444
2016
Q1
$434K Buy
4,573
+566
+14% +$47.8K 0.04% 615
2015
Q4
$362K Sell
4,007
-365
-8% -$31K 0.04% 635
2015
Q3
$406K Buy
4,372
+54
+1% +$4.76K 0.04% 651
2015
Q2
$284K Buy
4,318
+262
+6% +$17.4K 0.03% 1012
2015
Q1
$290K Buy
+4,056
New +$220K 0.04% 694

Other funds holding ABMD

Amalgamated Bank's ABMD Position: Q4 2022 in Review

Amalgamated Bank sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 11,966 shares — an estimated $2.94M sold.

Amalgamated Bank first reported a position in ABMD in Q1 2015 and held it in 31 quarters. The position peaked at $4.09M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Amalgamated Bank reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Amalgamated Bank sold 11,966 Abiomed Inc shares in Q4 2022, an estimated $2.94M.
  • Amalgamated Bank first reported a position in Abiomed Inc in Q1 2015 and held it in 31 quarters.
  • Amalgamated Bank's Abiomed Inc position peaked at $4.09M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Amalgamated Bank's 13F filing for Q4 2022, filed 10 Feb 2023.